Their platform promises substantial improvements to the accuracy of diagnosis and the efficacy of treatment of diseases like cancer, leveraging modern approaches in machine learning. Previously, Beck was an Associate Professor of Pathology at Harvard Medical School, where he published over 110 papers in cancer biology, pathology, and informatics.
